• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of new onset diabetes on pancreatic cancer outcomes.

作者信息

Borowsky Casey P, Hosein Peter J

机构信息

University of Miami Miller School of Medicine, Miami, FL, USA.

Division of Medical Oncology, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA.

出版信息

J Gastrointest Oncol. 2025 Aug 30;16(4):1782-1784. doi: 10.21037/jgo-2025-217. Epub 2025 Aug 25.

DOI:10.21037/jgo-2025-217
PMID:40950353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12432911/
Abstract
摘要

相似文献

1
Impact of new onset diabetes on pancreatic cancer outcomes.新发糖尿病对胰腺癌预后的影响。
J Gastrointest Oncol. 2025 Aug 30;16(4):1782-1784. doi: 10.21037/jgo-2025-217. Epub 2025 Aug 25.
2
Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.新发糖尿病对切除的胰腺导管腺癌复发的不良肿瘤学影响：与长期糖尿病患者和非糖尿病患者的比较
Pancreas. 2018 Aug;47(7):816-822. doi: 10.1097/MPA.0000000000001099.
3
Difference of Risk of Pancreatic Cancer in New-Onset Diabetes and Long-standing Diabetes: A Population-based Cohort Study.新发糖尿病与长期糖尿病患者患胰腺癌风险的差异：一项基于人群的队列研究。
J Clin Endocrinol Metab. 2023 May 17;108(6):1338-1347. doi: 10.1210/clinem/dgac728.
4
New-onset diabetes worsens prognosis of patients with pancreatic ductal adenocarcinoma after R0 resection: A multicenter study.
Hepatobiliary Pancreat Dis Int. 2025 Oct;24(5):543-549. doi: 10.1016/j.hbpd.2025.04.008. Epub 2025 May 2.
5
Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.根治性胰腺切除术后新发糖尿病的缓解可预测胰腺导管细胞腺癌患者的长期生存。
Ann Surg Oncol. 2013 Nov;20(12):3809-16. doi: 10.1245/s10434-013-3095-2. Epub 2013 Aug 14.
6
Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis.术前糖尿病对胰腺癌根治性切除术后长期生存的影响：一项系统评价和荟萃分析。
Ann Surg Oncol. 2014 Apr;21(4):1082-9. doi: 10.1245/s10434-013-3415-6. Epub 2013 Dec 10.
7
New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer.新发或恶化的糖尿病可能是胰腺癌早期诊断的线索。
Tohoku J Exp Med. 2020 Dec;252(4):353-364. doi: 10.1620/tjem.252.353.
8
New onset diabetes predicts clinical outcomes in patients with pancreatic adenocarcinoma.新发糖尿病可预测胰腺腺癌患者的临床结局。
J Gastrointest Oncol. 2025 Feb 28;16(1):226-233. doi: 10.21037/jgo-24-570. Epub 2025 Feb 26.
9
Clinical profiles and long-term outcomes of patients with pancreatic ductal adenocarcinoma and diabetes mellitus.患有胰腺导管腺癌和糖尿病患者的临床特征和长期预后。
Diabetes Metab Res Rev. 2012 Feb;28(2):169-76. doi: 10.1002/dmrr.1284.
10
Prevalence of New-Onset Diabetes in Patients Undergoing Pancreatic Surgery and the Association of Glucose Dysregulation With Complications in Pancreatic Cancer.接受胰腺手术患者新发糖尿病的患病率以及血糖失调与胰腺癌并发症的关联
Ann Surg Open. 2025 Jun 11;6(2):e584. doi: 10.1097/AS9.0000000000000584. eCollection 2025 Jun.

本文引用的文献

1
New onset diabetes predicts clinical outcomes in patients with pancreatic adenocarcinoma.新发糖尿病可预测胰腺腺癌患者的临床结局。
J Gastrointest Oncol. 2025 Feb 28;16(1):226-233. doi: 10.21037/jgo-24-570. Epub 2025 Feb 26.
2
Sorcin can trigger pancreatic cancer-associated new-onset diabetes through the secretion of inflammatory cytokines such as serpin E1 and CCL5.索辛（Sorcin）可通过分泌丝氨酸蛋白酶抑制剂E1（serpin E1）和CCL5等炎性细胞因子引发胰腺癌相关的新发糖尿病。
Exp Mol Med. 2024 Nov;56(11):2535-2547. doi: 10.1038/s12276-024-01346-4. Epub 2024 Nov 8.
3
Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus.胰腺癌中的糖尿病：针对新发糖尿病老年患者的独特方法
Cancers (Basel). 2023 Jul 19;15(14):3669. doi: 10.3390/cancers15143669.
4
The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival.多中心胰腺癌筛查研究：对分期和生存的影响。
J Clin Oncol. 2022 Oct 1;40(28):3257-3266. doi: 10.1200/JCO.22.00298. Epub 2022 Jun 15.
5
New-onset Diabetes as a Signpost of Early Pancreatic Cancer: The Role of Screening.新发糖尿病作为早期胰腺癌的标志：筛查的作用
Clin Gastroenterol Hepatol. 2022 Sep;20(9):1927-1930. doi: 10.1016/j.cgh.2022.02.015. Epub 2022 Feb 15.
6
Early Detection Initiative: A randomized controlled trial of algorithm-based screening in patients with new onset hyperglycemia and diabetes for early detection of pancreatic ductal adenocarcinoma.早期检测倡议：一项基于算法的筛查在新发高血糖和糖尿病患者中用于早期检测胰腺导管腺癌的随机对照试验。
Contemp Clin Trials. 2022 Feb;113:106659. doi: 10.1016/j.cct.2021.106659. Epub 2021 Dec 23.
7
Diabetes and pancreatic cancer: Exploring the two-way traffic.糖尿病与胰腺癌：探索双向交通。
World J Gastroenterol. 2021 Aug 14;27(30):4939-4962. doi: 10.3748/wjg.v27.i30.4939.
8
Early detection of pancreatic cancer.早期胰腺癌检测。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):698-710. doi: 10.1016/S2468-1253(19)30416-9. Epub 2020 Mar 2.
9
A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.一项建立新发糖尿病队列的前瞻性研究：来自慢性胰腺炎、糖尿病和胰腺癌研究联盟
Pancreas. 2018 Nov/Dec;47(10):1244-1248. doi: 10.1097/MPA.0000000000001169.
10
New-onset type 2 diabetes mellitus--A high-risk group suitable for the screening of pancreatic cancer?新发2型糖尿病——一个适合筛查胰腺癌的高危群体？
Pancreatology. 2016 Mar-Apr;16(2):266-71. doi: 10.1016/j.pan.2015.12.005. Epub 2015 Dec 23.